Cholesterol crystal embolism: Diagnosis and treatment

Kidney International

Volumn 69, Issue 8, 2006, Pages 1308-1312

  Meyrier, A ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Acute renal failure; Arteries; Cholesterol crystal embolism; Chronic renal failure; Clinical nephrology; Focal segmental glomerulosclerosis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CHOLESTEROL; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ILOPROST; PREDNISONE; VASODILATOR AGENT;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIHYPERTENSIVE THERAPY; ANURIA; AORTA ATHEROSCLEROSIS; AORTA PLAQUE ULCERATION; ARTERY SURGERY; ARTERY THROMBOSIS; ATHEROSCLEROSIS; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHOLESTEROL EMBOLISM; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DIURETIC THERAPY; DRUG EFFICACY; DRUG WITHDRAWAL; ENDARTERITIS; EOSINOPHILIA; GRAFT FAILURE; HUMAN; HYPERTENSION; INFLAMMATION; INTERVENTIONAL RADIOLOGY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY ISCHEMIA; MESENTERIC ARTERY OCCLUSION; MUSCLE DISEASE; NEPHROSCLEROSIS; OLIGURIA; PANCREAS BLOOD FLOW; PARENTERAL NUTRITION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIATION INJURY; RENAL ARTERY; RETINA DISEASE; SHORT SURVEY; SKIN DISEASE; SPINAL CORD DISEASE; STEROID THERAPY; SUBACUTE DISEASE; ULCER; ULTRAFILTRATION; VASCULAR SURGERY;

DIAGNOSIS, DIFFERENTIAL; EMBOLISM, CHOLESTEROL; HUMANS; ILOPROST; NEPHROSCLEROSIS; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 33646152118     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5000263     Document Type: Short Survey

References (26)

1. Scoble JE, O'donnell PJ. Renal atheroembolic disease: the Cinderella of nephrology. Nephrol Dial Transplant 1996; 11: 1516-1517.
2. Meyrier A, Hill GS, Simon P. Ischemic renal diseases: new insights in old entities. Kidney Int 1998; 54: 2-13.
3. Scolari F, Tardanico R, Zani R et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis 2000; 36: 1089-1109.
4. Saklayen MG. Atheroembolic renal disease. Preferential occurrence in whites only. Am J Nephrol 1989; 9: 87-88.
5. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology 1987; 42: 769-784.
6. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis 1999; 33: 840-850.
7. Thadhani R, Camargo C, Xavier R et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 biopsy-proven cases. Medicine 1995; 74: 350-358.
8. Meyrier A, Buchet P, Simon P et al. Atheromatous renal disease. Am J Med 1988; 85: 139-146.
9. Krishnamurthi V, Novick AC, Myles JL. Atheroembolic renal disease: effect on morbidity and survival after revascularization for atherosclerotic renal artery stenosis. J Urol 1999; 161: 1093-1096.
10. Glassock RJ, Ritz E, Bommer J et al. Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol 1984; 4: 193-200.
11. Scolari F, Tardanico R, Pola A et al. Cholesterol crystal embolic disease in renal allografts. J Nephrol 2003; 16: 139-143.
12. Cross SS. How common is cholesterol embolism? J Clin Pathol 1991; 44: 859-861.
13. Sabatine MS, Oelberg DA, Mark EJ, Kanarek D. Pulmonary cholesterol crystal embolization. Chest 1997; 112: 1687-1692.
14. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Am J Nephrol 1993; 13: 489-493.
15. Frock J, Bierman M, Hammeke M, Reyes A. Atheroembolic renal disease: experience with 22 patients. Nebr Med J 1994; 79: 317-321.
16. Greenberg A, Bastacky SI, Iqbal A et al. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism. Am J Kidney Dis 1987; 29: 334-344.
17. Gephardt GN, Tubbs R, Novick AC et al. Renal artery stenosis, nephrotic-range proteinuria, and focal and segmental glomerulosclerosis. Cleveland Clin Q 1984; 51: 371-376.
18. Thadhani R, Pascual M, Nickeleit V et al. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet 1996; 347: 231-233.
19. Conlon PJ, O'riordan E, Kalra PA. New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease. Am J Kidney Dis 2000; 35: 573-587.
20. Meyrier A. Mechanisms of disease: focal segmental glomerulosclerosis. Nat Clin Pract Nephrol 2005; 1: 44-54.
21. Zucchelli P, Zuccala A. The diagnostic dilemma of hypertensive nephrosclerosis: the nephrologist's view. Am J Kidney Dis 1993; 21: 87-91.
22. Kasinath BS, Corwin HL, Bidani AK et al. Eosinophilia in the diagnosis of atheroembolic renal disease. Am J Nephrol 1987; 7: 173-177.
23. Warren BA, Vanes O. The ultrastructure of the stages of atheroembolic occlusion of renal arteries. Br J Exp Pathol 1973; 54: 469-478.
24. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ 2002; 324: 268-269.
25. Corti R, Fuster V, Fayad ZA et al. Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: two years' follow-up by high resolution noninvasive magnetic resonance imaging. Circulation 2002; 106: 2884-2887.
26. Scolari F, Ravani P, Pola P et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol 2003; 14: 1584-1590.